Neuroscience Team Recognized as Unit of Distinction

Translate to Spanish or other 102 languages!

Colleagues from RGRH’s Critical Care - Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH
Colleagues from RGRH’s Critical Care – Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH

Mega Doctor News

- Advertisement -

McALLEN, Texas – Rio Grande Regional Hospital (RGRH) is proud and excited to announce that the Neuroscience team was recently recognized as a Recipient of the HCA Healthcare Critical Care – Progressive Care Unit of Distinction.  A total of 202 nursing units from across the country were recognized as top-performing nursing units. 

Units of Distinction are categorized in the top five percent of all HCA Healthcare medical-surgical, critical care, emergency services, surgical services, behavioral health, women’s and children’s nursing units, pediatrics/PICU, and inpatient rehabilitation units.  The top six to 10  percent of all HCA Healthcare units earned honorable mention designations. Our quality of care includes a multidisciplinary approach that consists of emergency room physicians, vascular-trained neurologists available 24-7, neurosurgeons, cardiologists, and an excellent rehabilitation team. 

Congratulations to the Neuroscience team for raising the bar and for their continued commitment to our mission, “Above all else, we are committed to the care and improvement of human life.”  

- Advertisement -

To learn more about the Stroke and Neurosciences programs, visit RioHealth.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Reveals Link Between Parent and Child Weight Is Mostly Genetic

The link between parents’ body mass index (BMI) and their children’s BMI in childhood is driven largely by genetic inheritance, rather than by any direct biological effects of parental weight during pregnancy, a new study suggests.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

The Genetic Armor Defeating Colorectal Cancer

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University, and institutions across the U.S., have published a landmark paper on the role of TGFBR1*6A, a naturally occurring genetic mutation in the TGFBR1 gene found in approximately 14 percent of the general population. Image for illustration purposes

Why CKM Syndrome Requires a Coordinated Care Point Person

When the term “cardiovascular-kidney-metabolic syndrome” was created in 2023 to define how heart disease, kidney disease, obesity and diabetes are connected, one goal was to help health professionals understand the benefits of working together.
- Advertisement -